Patents Examined by David B. Schmickel
-
Patent number: 5496731Abstract: The present invention relates to a broad-spectrum tumor suppressor gene and the protein expressed by that gene in appropriate host cells. The protein is a second in-frame AUG codon-initiated retinoblasoma protein of about 94 kD relative molecular mass. The present invention also relates to methods of treating a mammal having a disease or disorder characterized by abnormal cellular proliferation, such as a tumor or cancer and methods of treating abnormally proliferating cells, such as tumor or cancer cells. Treatment is accomplished by inserting a host cell compatible p94.sup.RB expression vector or an effective amount of p94.sup.RB protein into a cell or cells in need of treatment.Type: GrantFiled: March 25, 1993Date of Patent: March 5, 1996Inventors: Hong-Ji Xu, Shi-Xue Hu, William F. Benedict
-
Patent number: 5496724Abstract: An assay for screening snake venom for the presence or absence of platelet aggregation inhibitors (PAIs) based on specific receptor binding is described. Using this assay, the identification and characterization of PAIs in a wide range of snake venom samples was accomplished. The isolated and purified PAI from several of these active snake venoms is described and characterized. In addition, PAIs lacking the Arg-Gly-Asp (RGD) adhesion sequence but containing K*-(G/Sar)-D wherein K* is a modified lysyl residue of the formulaR.sup.1.sub.2 N(CH.sub.2).sub.4 CHNHCO--wherein each R.sup.1 is independently H, alkyl(1-6C) or at most one R.sup.1 is R.sup.2 --C.dbd.NR.sup.3 wherein R.sup.2 is H, alkyl(1-6C) or is NR.sup.4.sub.2 in which each R.sup.4 is independently H or alkyl(1-6C) and R.sup.3 is H, alkyl(1-6C), phenyl or benzyl, or R.sup.2 --C.dbd.NR.sup.3 is a radical selected from the group consisting of: ##STR1## where m is an integer of 2-3, and each R.sup.Type: GrantFiled: May 24, 1993Date of Patent: March 5, 1996Assignee: COR Therapeutics, Inc.Inventors: Robert M. Scarborough, David L. Wolf, Israel F. Charo
-
Patent number: 5482923Abstract: Circulating heparin in a mammal may be neutralized without substantial depletion of platelets or leukocytes by administering to the mammal a heparin neutralizing amount of a purified heparin binding fragment of PF4 or of recombinant PF4.Type: GrantFiled: April 16, 1993Date of Patent: January 9, 1996Assignee: Repligen CorporationInventor: Theodore E. Maione
-
Patent number: 5480801Abstract: The present invention relates to isolated nucleic acid fragments containing a sequence encoding a Rhizoctonia solani laccase having optimum activity at a neutral or basic pH. and the laccase proteins encoded thereby.Type: GrantFiled: December 22, 1993Date of Patent: January 2, 1996Assignee: Novo Nordisk A/SInventors: Jill A. Wahleithner, Bjoern E. Christensen, Palle Schneider
-
Patent number: 5470740Abstract: The present invention discloses the cloning and expression in Escherichia coli of the NsiI restriction-modification system from Neisseria sicca, utilizing a two step protocol. Initial protection of E. coli host with methylase expressed on a plasmid was required to stabilize a compatible plasmid carrying the endonuclease gene on a single DNA fragment. A chromosomal map was generated localizing the genes for NsiI methylase and endonuclease. An E. coli strain was constructed which produced high levels of NsiI endonuclease.Type: GrantFiled: November 4, 1993Date of Patent: November 28, 1995Assignee: Life Technologies, Inc.Inventors: Mary C. Longo, Michael D. Smith
-
Patent number: 5468636Abstract: The subject invention concerns Bacillus thuringiensis isolates designated B.t. PS157C1, B.t. PS86A1, and B.t. PS75J1, which are active against aphid pests. Thus, these isolates, or variants thereof, can be used to control such pests. Further, genes encoding novel .delta.-endotoxins can be removed from these isolates and transferred to other host microbes, or plants. Expression of the .delta.-endotoxins in microbe hosts results in the control of aphid pests, whereas transformed plants become resistant to aphid pests.Type: GrantFiled: November 3, 1993Date of Patent: November 21, 1995Assignee: Mycogen CorporationInventors: Jewel M. Payne, Raymond J. C. Cannon, H. Ernest Schnepf, George E. Schwab
-
Patent number: 5444153Abstract: Variants of the plasminogen activator inhibitor PAI-2 in which the 66-98 amino acid residue region has been altered to eliminate at least one protease sensitive site are provided. The variants of the invention maintain the biological activity of PAI-2 and amino acids up to 65 and from 99 of PAI-2 in frame. The PAI-2 variants of the invention in labelled form, as well as DNA molecules encoding the variants of the invention, transformed host cells expressing the variants of the invention compositions and diagnostic kits comprising the variants of the invention, antibodies against the variants of the invention and processes for the production of the variants, DNA molecules, transformed hosts, compositions and antibodies of the invention are also described.Type: GrantFiled: October 11, 1991Date of Patent: August 22, 1995Assignee: Biotech Australia Pty LimitedInventors: Neil H. Goss, Michael A. Richardson
-
Patent number: 5354676Abstract: A recombinant thermophilic NAD-dependent dehydrogenase having a hydrophobic amino acid at position 104 and/or 102. The enzymes are effective in catalysing the dehydrogenation of homologues of pyruvic acid of formula CnH.sub.2n+1 COCOOH, wherein n is>1, to homologues of lactic acid of formula CH.sub.n H.sub.2n+1 CHOHCOOH, wherein n is>1.Type: GrantFiled: October 24, 1991Date of Patent: October 11, 1994Assignees: The University of Bristol, Public Health Laboratory Service BoardInventors: William N. Chia, Anthony R. Clarke, Joseph J. Holbrook, Helen M. Wilks, Anthony Atkinson
-
Patent number: 5324637Abstract: A method for coupling transcription and translation from DNA using a solution comprising a eukaryotic cell-free extract comprising adding a sufficient amount of a magnesium compound to the extract to raise the magnesium concentration to a level where RNA is transcribed from DNA and RNA translates into protein.Type: GrantFiled: November 9, 1993Date of Patent: June 28, 1994Assignee: Promega CorporationInventors: David V. Thompson, Thomas R. Van Oosbree
-
Patent number: 5324660Abstract: The isolation and characterization of genes involved in proteolytic processing in species of the genus Pichia is described. The availability of such genes has enabled the generation of strains of Pichia which are deficient in proteolytic activity, which strains are useful as hosts for the expression of proteolytically sensitive recombinant products. The isolation and characterization of additional genes from species of the genus Pichia is also described, as well as uses therefore.Type: GrantFiled: July 6, 1993Date of Patent: June 28, 1994Assignee: The Salk Institute Biotechnology/Industrial Assoc. Inc.Inventors: Martin A. Gleeson, Bradley D. Howard
-
Patent number: 5324715Abstract: A protein isolated from crude Haementeria officinalis extract which blocks stimulation of platelet aggregation by collagen. The protein has a molecular weight of approximately 16,000. A method of isolating the protein and using the protein to prevent or delay blood coagulation by blocking the stimulation of platelet aggregation by collagen is also described. The protein is useful in the prevention, prophylaxis, therapy and treatment of thrombotic diseases.Type: GrantFiled: April 7, 1993Date of Patent: June 28, 1994Assignee: Merck & Co., Inc.Inventors: Thomas M. Connolly, Paul M. Keller
-
Patent number: 5318899Abstract: An assay for screening snake venom for the presence or absence of platelet aggregation inhibitors (PAIs) based on specific receptor binding is described. Using this assay, the identification and characterization of PAIs in a wide range of snake venom samples was accomplished. The isolated and purified PAI from several of these active snake venoms is described and characterized. In addition, PAIs lacking the Arg-Gly-Asp (RGD) adhesion sequence but containing K.sup.* -(G/Sar)-D wherein K.sup.* is a modified lysyl residue of the formulaR.sup.1.sub.2 N(CH.sub.2).sub.4 CHNHCO--wherein each R.sup.1 is independently H, alkyl(1-6C) or at most one R.sup.1 is R.sup.2 --C.dbd.NR.sup.3 wherein R.sup.2 is H, alkyl(1-6C) or is NR.sup.4.sub.2 in which each R.sup.4 is independently H or alkyl(1-6C) and R.sup.3 is H, alkyl(1-6C), phenyl or benzyl, or R.sup.2 --C=NR.sup.3 is a radical selected from the group consisting of: ##STR1## where m is an integer of 2-3, and each R.sup.Type: GrantFiled: February 20, 1990Date of Patent: June 7, 1994Assignee: COR Therapeutics, Inc.Inventors: Robert M. Scarborough, David L. Wolf, Israel F. Charo
-
Patent number: 5312750Abstract: A GL-7ACA acylase having the following characteristics:(a) has ability to catalyze the enzymatic conversion of glutaryl 7-ACA, adipyl 7-ACA, and succinyl 7-ACA, into 7-aminocephalosporanic acid,(b) has a molecular weight of 70,000 dalton (SDS-PAGE) and(c) has N-terminal amino acid sequence (sea in No: 1) thereof: Gln-Ser-Glu-Gln-Glu-Lys-Ala-Glu-Glu-.A process for producing GL-7ACA acylase is also provided.Type: GrantFiled: June 22, 1993Date of Patent: May 17, 1994Assignee: Fujisawa Pharmaceutical Co., Ltd.Inventors: Ichiro Aramori, Masao Fukagawa, Hiroki Ono, Yosuke Ishitani, Mana Tsumura, Morita Iwami, Hitoshi Kojo
-
Patent number: 5308770Abstract: The invention concerns a glucose-6-phosphate dehydrogenase which contains the amino acid sequence shown in SEQ ID NO:1 as well as a DNA coding for it and a process for the isolation of an enzyme according to the present invention.Type: GrantFiled: February 25, 1993Date of Patent: May 3, 1994Assignee: Boehringer Mannheim GmbHInventors: Michael Jarsch, Gunter Lang
-
Patent number: 5262324Abstract: Certain known and available strains of Bacillus thuringiensis (B.t.) have been found to have activity against coleopteran pests. Previously, these strains were not known to have any insecticidal properties. The B.t.strains can be used in various environments to control coleopteran pests, e.g., the Colorado Potato Beetle.Type: GrantFiled: November 6, 1991Date of Patent: November 16, 1993Assignee: Mycogen CorporationInventor: Jewel M. Payne